(1 - 11 von 14
)
VolitionRx Announces First Published Data in Anticancer Research...
www.irdirect.net
... by Dr. Stefan Holdenrieder at the Institute of Clinical Chemistry and ... website (www.volitionrx.com) or connect with us on Twitter, LinkedIn, ...
VolitionRx Extends Agreement With University Hospital Bonn
www.globenewswire.com
Dr. Stefan Holdenrieder at the Institute of Clinical Chemistry and ... (www.volitionrx.com) or connect with us via Twitter, LinkedIn or Facebook.
VolitionRx Extends Agreement With University Hospital Bonn to Include...
www.wallstreet-online.de
The CE mark performance evaluation will be led by Priv-Doz. Dr. Stefan Holdenrieder at the Institute of Clinical Chemistry and Clinical Pharmacology, University
sortiert nach Relevanz / Datum